Literature DB >> 7030512

Is aldosterone secretion under dopaminergic control?

D J Campbell, F A Mendelsohn, W R Adam, J W Funder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7030512     DOI： 10.1161/01.res.49.6.1217

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  4 in total

1.  Effects of the dopaminergic agonist cianergoline on blood pressure, the renin-angiotensin-aldosterone axis and the sympathetic nervous system in patients with essential hypertension.

Authors:  G Bise; C Foletti; C Beretta-Piccoli; P Weidmann; W H Ziegler; R Mordasini; C Bachmann
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.

Authors:  C Barbieri; M Parodi; S Bruno; F Bertassi; D Benaglia; P Moser; R Meroni; A Dubini
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.

Authors:  J N Harvey; D P Worth; J Brown; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

Review 4.  Drug administration in chronic liver disease.

Authors:  J F Westphal; J M Brogard
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.228
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.